Evidence map›Paper›PMID 41670864›Full record

ArticleMolecular biology reports2026

amiR414e-mediated silencing confers resistance to Cotton leaf curl Multan virus in cotton.

Masnad Khan, Jawaid A Khan

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Masnad KhanPlant Virus Laboratory, Department of Biosciences, Jamia Millia Islamia, New Delhi, 110025, India.
Jawaid A KhanPlant Virus Laboratory, Department of Biosciences, Jamia Millia Islamia, New Delhi, 110025, India. jkhan1@jmi.ac.in.ORCID http://orcid.org/0000-0001-7191-5804

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCotton leaf curl disease (CLCuD), caused by monopartite begomoviruses in association with satellite molecules, remains a serious threat to cotton production in the Indian subcontinent. Conventional control strategies have shown limited success, whereas RNA interference (RNAi) has emerged as an effective antiviral approach.

methodsA synthetic artificial (a) miR414e was engineered to target the overlapping regions of the C1 and C4 genes of Cotton leaf curl Multan virus (CLCuMuV). The pre-amiR414e construct was cloned in the pBI121 vector and transformed into Gossypium hirsutum cv. HS6. Molecular analyses were conducted using PCR and quantitative real-time PCR (qRT-PCR).

resultsTransgenic cotton plants expressing amiR414e were successfully developed, and the transgene exhibited expected Mendelian inheritance patterns in the T1 and T2 generations. At 60 days post inoculation (dpi), PCR assay failed to detect CLCuMuV in all the asymptomatic plants, demonstrating a high degree of resistance in both T1 (80–90%) and T2 (60–72%) lines. Additionally, transgenic (T2) lines overexpressing amiR414e showed significant downregulation of C1 gene transcripts (51–78%), revealing a negative correlation between amiR414e and the C1 gene accumulation.

conclusionIn this study, expression of amiR414e in G. hirsutum cv. HS6 conferred heritable resistance against CLCuMuV, with most of the transgenic plants remaining asymptomatic. These findings demonstrate the potential of amiRNA-mediated gene silencing as a viable and precise strategy for developing CLCuMuV-resistant cotton cultivars.

Indexed as

BegomovirusDisease ResistanceGossypiumMicroRNAsPlant DiseasesGene SilencingPlants, Genetically ModifiedRNA InterferenceMicroRNAsArtificial MicroRNABegomovirusCLCuMuVGossypium hirsutumRNA silencingTransformation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.